Medshield Products

Hand Sanitizer


Hwl Holdings, Llc
Human Otc Drug
NDC 75446-123
Medshield Products also known as Hand Sanitizer is a human otc drug labeled by 'Hwl Holdings, Llc'. National Drug Code (NDC) number for Medshield Products is 75446-123. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Medshield Products drug includes Benzalkonium Chloride - 1 ug/mL . The currest status of Medshield Products drug is Active.

Drug Information:

Drug NDC: 75446-123
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Medshield Products
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Hand Sanitizer
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hwl Holdings, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:BENZALKONIUM CHLORIDE - 1 ug/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 27 Apr, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 20 Dec, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 04 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:HWL Holdings, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0860004195207
UPC stands for Universal Product Code.
UNII:F5UM2KM3W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
75446-123-0159 mL in 1 BOTTLE, PLASTIC (75446-123-01)15 Sep, 202020 Dec, 2023No
75446-123-02100 mL in 1 BOTTLE, PLASTIC (75446-123-02)15 Sep, 202020 Dec, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic, hand sanitizer

Product Elements:

Medshield products hand sanitizer glycerin water benzalkonium chloride benzalkonium

Indications and Usage:

Use to decrease bacteria on the skin that could cause disease

Warnings:

Warnings for external use only-hands

When Using:

Keep out of eyes in case of contact with eyes, rinse eyes thoroughly with water.

Dosage and Administration:

Directions rub thoroughly over all the surfaces of both hands. rub hands together briskly until dry.

Stop Use:

If skin irritation develops.

Package Label Principal Display Panel:

Package label - principal display panel 100 ml ndc: 75446-123-02 100 ml ndc: 75446-111-14


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.